Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to $683.6 million.

  • P3 Health Partners' Liabilities and Shareholders Equity fell 1797.23% to $683.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year decrease of 1337.63%. This contributed to the annual value of $783.4 million for FY2024, which is 900.7% down from last year.
  • Latest data reveals that P3 Health Partners reported Liabilities and Shareholders Equity of $683.6 million as of Q3 2025, which was down 1797.23% from $731.6 million recorded in Q2 2025.
  • In the past 5 years, P3 Health Partners' Liabilities and Shareholders Equity ranged from a high of $2.4 billion in Q1 2022 and a low of $100.7 million during Q1 2021
  • For the 5-year period, P3 Health Partners' Liabilities and Shareholders Equity averaged around $883.0 million, with its median value being $858.4 million (2023).
  • In the last 5 years, P3 Health Partners' Liabilities and Shareholders Equity soared by 223973.22% in 2022 and then plummeted by 6319.24% in 2023.
  • Quarter analysis of 5 years shows P3 Health Partners' Liabilities and Shareholders Equity stood at $316.6 million in 2021, then surged by 176.85% to $876.6 million in 2022, then decreased by 1.78% to $861.0 million in 2023, then fell by 9.01% to $783.4 million in 2024, then decreased by 12.75% to $683.6 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $683.6 million for Q3 2025, versus $731.6 million for Q2 2025 and $783.9 million for Q1 2025.